20-960442-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001029871.4(RSPO4):c.620G>A(p.Gly207Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000461 in 1,539,546 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001029871.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RSPO4 | NM_001029871.4 | c.620G>A | p.Gly207Asp | missense_variant | 5/5 | ENST00000217260.9 | |
RSPO4 | NM_001040007.3 | c.434G>A | p.Gly145Asp | missense_variant | 4/4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RSPO4 | ENST00000217260.9 | c.620G>A | p.Gly207Asp | missense_variant | 5/5 | 1 | NM_001029871.4 | P1 | |
RSPO4 | ENST00000400634.2 | c.434G>A | p.Gly145Asp | missense_variant | 4/4 | 1 |
Frequencies
GnomAD3 genomes AF: 0.000230 AC: 35AN: 152198Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000416 AC: 6AN: 144394Hom.: 0 AF XY: 0.0000388 AC XY: 3AN XY: 77278
GnomAD4 exome AF: 0.0000259 AC: 36AN: 1387348Hom.: 0 Cov.: 31 AF XY: 0.0000131 AC XY: 9AN XY: 684750
GnomAD4 genome AF: 0.000230 AC: 35AN: 152198Hom.: 0 Cov.: 33 AF XY: 0.000377 AC XY: 28AN XY: 74342
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 23, 2024 | The c.620G>A (p.G207D) alteration is located in exon 5 (coding exon 5) of the RSPO4 gene. This alteration results from a G to A substitution at nucleotide position 620, causing the glycine (G) at amino acid position 207 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at